UnknownPhase 1NCT00855608

Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rafic Hariri University Hospital
Principal Investigator
ahmad m mansour, md
RHUH
Intervention
adalimumab(drug)
Enrollment
15 target
Eligibility
17-88 years · All sexes
Timeline
20092013

Study locations (1)

Collaborators

American University of Beirut Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00855608 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials